Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people. A new study, however, suggests that it may now be easier to predict who is most likely to suffer with more serious disease symptoms based on leukocyte (white blood cell) count.

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

With a recent surge in influenza, COVID-19, norovirus, respiratory syncytial virus (RSV), and other respiratory viruses, it's critical to pay close attention to your heart and symptoms—especially if you have heart disease or the risk factors for it.

Jan. 20, 2025, marks five years since the CDC reported the first laboratory-confirmed case of COVID-19 on American soil.

Over 160,000 people this season have landed in the hospital from flu complications, CDC estimates. More than 6,600 have died. Here's the symptoms.

Thousands of Oklahomans are sick with the flu. Symptoms of influenza include chills, fever, cough and body aches.

COVID-19 vaccination reduces severity of acute disease, but does not decrease neurological manifestations of Long COVID.

Study highlights a fourfold increase in ME/CFS risk among COVID-19 patients, with 89% of post-COVID ME/CFS cases overlapping with severe long COVID symptom clusters.

A KiwiRail engineer experiencing after-effects of Covid-19 failed to stop at a red signal nearly causing a train collision last year, the investigation fin

‘Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection’ by Eugene P. Duff et al. was published in Nature Medicine at 10:00 UK time on Thursday 30th January.

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people. A new study, however, suggests that it may now be easier to predict who is most likely to suffer with more serious disease symptoms based on leukocyte (white blood cell) count.

Researchers tracking nearly 1,000 individuals with post-COVID-19 syndrome observed minimal changes in their symptoms during the second year of the illness. A new study published in the open-access jou